Related Experiment Videos

Phototherapy for hyperbilirubinaemia in very low birthweight infants

Insights

Phototherapy effectively manages high bilirubin levels in premature infants under 1500g. Close monitoring on days two and three is recommended for timely intervention in very low birthweight neonates.

Area of Science:

  • Neonatal Medicine
  • Pediatric Phototherapy
  • Bilirubin Metabolism

Background:

  • Hyperbilirubinemia is a common concern in newborns.
  • Very low birthweight infants (<1500g) are particularly susceptible to complications from elevated bilirubin.
  • Phototherapy is a standard treatment for neonatal jaundice.

Purpose of the Study:

  • To evaluate the efficacy of phototherapy in controlling plasma bilirubin levels in very low birthweight infants.
  • To determine if phototherapy can maintain bilirubin below critical thresholds in this vulnerable population.

Main Methods:

  • Phototherapy was administered to 20 neonates with birthweights below 1500g.
  • Plasma bilirubin levels were monitored.
  • Treatment was initiated when bilirubin exceeded 8 mg/100 ml.

Main Results:

  • Phototherapy successfully maintained plasma bilirubin below 13 mg/100 ml in most infants.
  • Four infants required treatment before reaching 13 mg/100 ml, a rate lower than in larger, untreated infants.
  • The treatment demonstrated satisfactory control of bilirubin levels in this cohort.

Conclusions:

  • Phototherapy is an effective method for managing hyperbilirubinemia in very low birthweight infants.
  • Frequent plasma bilirubin monitoring on the second and third days of life is crucial for prompt initiation of phototherapy.
  • Early intervention is key to preventing complications associated with neonatal jaundice in premature infants.

Related Concept Videos